The role of the sPAP/PAAT ratio in detecting PAH was demonstrated by Serra and Chetta, though their study was limited by a small patient cohort (63 with SSc and 60 controls) and a limited number of patients evaluated via RHC [53]. The gene discussed is PDZK1IP1; the disease is systemic sclerosis.